Patents Assigned to Bayer
  • Patent number: 6803026
    Abstract: This invention relates to carbon black pellets obtained by compaction of carbon black powder in the presence of auxiliary substances, which pellets, despite the compaction, surprisingly exhibit greater color intensity than the powders on which they are based.
    Type: Grant
    Filed: September 14, 2000
    Date of Patent: October 12, 2004
    Assignee: Bayer Chemicals AG
    Inventors: Günter Linde, Uwe Hempelmann, Manfred Eitel
  • Patent number: 6800781
    Abstract: The present invention provides a process for quenching a gaseous reaction mixture during the phosgenation of diamines in the gas phase to produce diisocyanates. The gaseous reaction mixture contains at least a diisocyanate, phosgene and hydrogen chloride. The quenching liquid is injected into the gas mixture continuously flowing out of a cylindrical reaction zone into the downstream cylindrical quenching zone with the aid of at least two spray nozzles which are arranged at the entrance to the quenching zone at equal distances along the circumference of the quenching zone.
    Type: Grant
    Filed: September 25, 2003
    Date of Patent: October 5, 2004
    Assignee: Bayer Aktiengesellschaft
    Inventors: Heiko Herold, Herbert Stutz, Hans-Joachim Brockhaus, Volker Michele
  • Patent number: 6800794
    Abstract: The invention concerns plants with improved resistance to certain stilbene-sensitive pathogenic agents, and more particularly a set of constructs combining a plant promoter inductible by biotic stress, generated in particular by said pathogens, and gene(s) coding f r a stilbene synthase.
    Type: Grant
    Filed: January 2, 2001
    Date of Patent: October 5, 2004
    Assignees: Champagne Moet & Chandon, Bayer Aktiengesellschaft
    Inventors: Pierre Coutos-Thevenot, Rüdiger Hain, Peter-Helmut Schreier, Michel Boulay, Robert Esnault
  • Patent number: 6800708
    Abstract: The invention relates to a new process for the preparation of functionalized telechelics based on vinyl polymers, the telechelics prepared in this way and their use in the plastics, fibers or coating sector.
    Type: Grant
    Filed: April 7, 2003
    Date of Patent: October 5, 2004
    Assignee: Bayer Aktiengesellschaft
    Inventors: Martin Melchiors, Hartwig Höcker, Helmut Keul, Dirk Achten
  • Patent number: 6800780
    Abstract: Disclosed herein is a process for the preparation of carboxylic acid benzyl esters from dibenzyl ethers, comprising reacting dibenzyl ethers with carboxylic acids in the presence of a homogeneous acidic catalyst.
    Type: Grant
    Filed: September 25, 2002
    Date of Patent: October 5, 2004
    Assignee: Bayer Aktiengesellschaft
    Inventors: Pieter Ooms, Ursula Jansen, Bernd-Ulrich Schenke
  • Publication number: 20040192580
    Abstract: Reagents that regulate human ceramide kinase protein activity and reagents that bind to human ceramide kinase gene products can be used to regulate intracellular signaling and consequently cell proliferation and apoptosis. Such regulation is particularly useful for treating allergies including but not limited to asthma, autoimmune diseases such as rheumatoid arthritis, inflammatory disease, transplant rejection, and cancer, particularly lymphocytic leukemias, and could be a useful target of vaccination enhancing adjuvants. Central and peripheral nervous system disorders, such as Parkinson's disease, also can be treated.
    Type: Application
    Filed: December 19, 2003
    Publication date: September 30, 2004
    Applicant: Bayer Aktiengesellschaft
    Inventors: Sophia Kossida, Jeffrey Encinas, Eiko Takao
  • Publication number: 20040191819
    Abstract: The present invention relates to gene expression profiles for breast cancer, microarrays comprising nucleic acid sequences representing gene expression profiles, and methods of using expression profiles and microarrays. The invention also provides methods and compositions for diagnostic assays for detecting cancer and therapeutic methods and compositions for treating cancer. The invention also provides methods for designing, identifying, and optimizing therapeutics for cancer.
    Type: Application
    Filed: February 27, 2004
    Publication date: September 30, 2004
    Applicant: Bayer Pharmaceuticals Corporation
    Inventors: Deepa Eveleigh, Douglas Bigwood
  • Patent number: 6797837
    Abstract: A process for preparing an emulsion is disclosed. The process entails mixing an aqueous mineral acid that contains phosphorous in an organic solvent, the mixing being continuous and with the degree of intensity sufficient to form a homogeneous emulsion. The emulsion prepared by the process is useful in the process of preparing polycarbonate by the interfacial process. Accordingly the washed organic polycarbonate that has been washed without the use of a phosphorous containing mineral acid solution is mixed with the novel emulsion. The resulting polycarbonate is characterized by its improved thermal stability.
    Type: Grant
    Filed: April 4, 2003
    Date of Patent: September 28, 2004
    Assignee: Bayer Aktiengesellschaft
    Inventors: Christian Kords, Jürgen Heuser, Antonio Ortiz
  • Patent number: 6797665
    Abstract: The invention relates to double-metal cyanide catalysts for preparing polyols by the polyaddition of alkylene oxides on to starter compounds containing active hydrogen atoms, wherein the DMC catalysts are composed of: a) at least one double-metal cyanide compound; b) at least one organic complexing ligand; and, optionally, c) at least one functionalized polymer, wherein the organic complexing ligand is a mixture of a C3-C7 aliphatic alcohol and from about 2 to about 98 mole %, based on the total amount of organic complexing ligand, of a cyclic, aliphatic, cycloaliphatic or aromatic ketone. The DMC catalysts of the present invention have increased activity compared to known catalysts. Additionally, the DMC catalysts of the present invention can be used to prepare polyols with reduced high molecular weight components.
    Type: Grant
    Filed: May 10, 2002
    Date of Patent: September 28, 2004
    Assignee: Bayer Antwerpen
    Inventor: Bi Le-Khac
  • Patent number: 6797861
    Abstract: “The present invention relates to DNA sequences, comprising nucleic acid fragments encoding dehiscence zone-selective proteins, particularly cell wall hydrolases such as polygalacturonases, and their use for modifying dehiscence properties in plants, more particularly pod dehiscence properties in Brassica napus.
    Type: Grant
    Filed: May 21, 2002
    Date of Patent: September 28, 2004
    Assignee: Bayer BioScience NV
    Inventors: Peter Ulvskov, Robin Child, Henri Van Onckelen, Els Prinsen, Bernhard Borkhardt, Lilli Sander, Morten Petersen, Gert Bundgard Poulsen, Johan Botterman
  • Patent number: 6797800
    Abstract: The invention relates to a method of preparing a polyisocyanate with at least one uretdione group by oligomerizing part of the isocyanate groups of isophorone diisocyanate in the presence of a catalyst which accelerates the dimerization of isocyanate groups, wherein the oligomerization catalyst comprises a saline compound comprising from 10 to 100 wt. % of 1,2,3- and/or 1,2,4-triazolate structures (calculated as C2N3; molecular weight=66) in the anion, and the products prepared by this method.
    Type: Grant
    Filed: May 13, 2002
    Date of Patent: September 28, 2004
    Assignee: Bayer Aktiengesellschaft
    Inventors: Hans-Josef Laas, Reinhard Halpaap, Frank Richter, Jürgen Köcher
  • Patent number: 6797670
    Abstract: The invention relates to microcapsules for which the walls comprise reaction products of polyisocyanates, guanidine compounds, and optionally amines, wherein the polyisocyanates have an isocyanurate content of at least 30% by weight, based on polyisocyanate, and the walls comprise on average less than 9% by weight, based on the total weight of the microcapsule.
    Type: Grant
    Filed: October 11, 2001
    Date of Patent: September 28, 2004
    Assignee: Bayer Aktiengesellschaft
    Inventors: Martin Kleban, Günter Klug, Jürgen Weisser
  • Patent number: 6797784
    Abstract: The invention relates to homopolymers and/or copolymers containing <100 ppm coarse particles with a particle diameter of between 200 and 500 &mgr;m, to thermoplastic moulding materials containing said homopolymtrs and/or copolymers, to the use of the homopolymers and/or copolymers and moulding materials for the production of moulded parts and to the moulded parts themselves.
    Type: Grant
    Filed: May 3, 2001
    Date of Patent: September 28, 2004
    Assignee: Bayer Aktiengesellschaft
    Inventors: Michael Zobel, Dieter Wittmann, Herbert Eichenauer, Alfred Eitel, Thomas Eckel, Bernd Keller, Hans-Bernhard Hauertmann, Dorothy Rose
  • Patent number: 6797714
    Abstract: This invention is related to novel carboxyl substituted chroman derivatives which are useful in the treatment of beta-3 receptor mediated conditions.
    Type: Grant
    Filed: August 21, 2002
    Date of Patent: September 28, 2004
    Assignee: Bayer Pharmaceuticals Corporation
    Inventors: Richard D. Connell, Timothy G. Lease, Jeremy L. Baryza
  • Patent number: 6797799
    Abstract: The present invention provides NCO prepolymers comprising the reaction product of (1) an allophanate-modified diphenylmethane diisocyanate having an NCO group content of 12 to 32.5% by weight and comprising the reaction product of, (a) an aliphatic alcohol or an aromatic alcohol; and (b) diphenylmethane diisocyanate comprising: (i) from 10 to 60% by weight of 2,4′-diphenylmethane diisocyanate, (ii) less than 6% by weight of 2,2′-diphenylmethane diisocyanate, and (iii) the balance being 4,4′-diphenylmethane diisocyanate, wherein the sum of the percentages by weight of (1)(b)(i), (1)(b)(ii), and (1)(b)(iii) total 100% by weight of (1)(b), and (2) a polyether polyol having a molecular weight of 134 to 10,000, an OH number of 420 to 14, and a functionality of at least 1.8. The NCO prepolymers of the present invention find use in preparing elastomeric coatings, adhesives, sealants, and the like.
    Type: Grant
    Filed: April 2, 2003
    Date of Patent: September 28, 2004
    Assignee: Bayer Materialscience LLC
    Inventors: William E. Slack, Edward P. Squiller, P. Richard Hergenrother
  • Publication number: 20040182556
    Abstract: High performance thermal control duct for heat exchangers, comprising two sheets, each of which have surface depressions, sandwiched together on both sides of a holed sheet.
    Type: Application
    Filed: October 2, 2003
    Publication date: September 23, 2004
    Applicant: Bayer Aktiengesellschaft
    Inventors: Peter Jahn, Klaus Ochmann
  • Publication number: 20040186106
    Abstract: The present invention relates to substituted phenylcyclohexanecarboxamides of the formula (I) having adenosine-uptake-inhibiting action, to a process for their preparation and to their use in medicaments, in particular for treating ischaemic brain disorders.
    Type: Application
    Filed: March 18, 2004
    Publication date: September 23, 2004
    Applicant: Bayer Healthcare AG
    Inventors: Wolf-Dietrich Freund, Stephan Lensky, Stephan-Nicholas Muller, Holger Paulsen, Jorg Keldenich, Ervin Horvath, Joachim Schuhmacher
  • Patent number: 6794452
    Abstract: Polymeric materials that differ from each other in solubility parameters and other properties are covulcanized by reaction with a hydrogenated carboxylated nitrile rubber, a multivalent salt of an organic acid and a curing agent.
    Type: Grant
    Filed: July 15, 2002
    Date of Patent: September 21, 2004
    Assignee: Bayer Inc.
    Inventor: Carl Walter von Hellens
  • Patent number: 6794559
    Abstract: The present invention provides promoters which bring about a caryopsis-specific expression of coding nucleotide sequences controlled by them, and to expression cassettes, recombinant vectors and host cells containing such promoters. Transformed transgenic plant cells and plants and methods for generating them, are also described.
    Type: Grant
    Filed: July 5, 2001
    Date of Patent: September 21, 2004
    Assignee: Bayer CropScience GmbH
    Inventors: Stefanie Sprunck, Antje Kluth, Dirk Becker, Stephanie Luetticke, Horst Loerz
  • Patent number: 6794149
    Abstract: The invention relates to polypeptides which exert the biological activity of GABA B receptors, and to nucleic acids which encode these polypeptides, and in particular to their use for finding active compounds for crop protection.
    Type: Grant
    Filed: November 17, 2000
    Date of Patent: September 21, 2004
    Assignee: Bayer Aktiengesellschaft
    Inventors: Klaus Raming, Mario Mezler, Thomas Müller